Form 4: Candel Therapeutics Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
William Garrett Nichols, Chief Medical Officer of Candel Therapeutics, sold 9,769 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On July 11, 2024, William Garrett Nichols, the Chief Medical Officer of Candel Therapeutics, sold 9,769 shares of the company's common stock.
- The sale was executed at a price of $5.9734 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted stock units, as per the Issuer's mandatory sell to cover policy.
- Following the transaction, Nichols directly owns 125,357 shares of Candel Therapeutics.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations and doesn't indicate a change in the executive's confidence in the company.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of the stock sale transaction. |
| 07/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.